January Trading Activity Analysis

The January 2024 trading period commenced with a robust starting capital of $13,761,291.44, reflecting the account's substantial equity base at AtlasEquityAsset Pro. Throughout this period, the account executed a diversified range of trades across multiple equity symbols, demonstrating active portfolio management and strategic positioning in volatile market conditions.

The net realized loss of ($1,256,717.52) for January represents approximately 9.1% of the starting capital. This drawdown was primarily driven by concentrated losses in high-beta momentum stocks including MRNA with a significant unrealized delta of ($1,769,261.53), AMC at ($105,959.38), and ACY at ($76,245.39). These positions reflected aggressive short-term trading strategies targeting meme-stock volatility and biotech catalyst events.

Offsetting these losses, the account captured substantial gains in SPRT (+$399,640.12), HOOD (+$184,992.98), and RGC (+$55,163.13), showcasing the trader's ability to identify asymmetric risk-reward opportunities. The commission structure totaled $3,862.50 across 1,542 orders and 47,760 fills, with ECN fees of ($3,768.999) and regulatory fees (SEC, ORF, TAF, NFA) aggregating to $11,773.40.

• Total equity symbols traded: 24 distinct tickers
• Average commission per order: $2.50
• Total shares exchanged: 7,354,988
• Gross trading loss before fees: ($1,244,850.62)
• Final settlement cash position: $12,504,573.93

April Account Summary & Balance Reconciliation

The April 2024 monthly statement provides a comprehensive reconciliation of the trading account's financial position across both Trade Date and Settlement Date methodologies. At the commencement of the period (April 1, 2024), the account maintained a Trade Date Balance and Equity of $4,000,000.00, with zero long or short market value positions — indicating a fully liquid cash posture at month-start.

By the close of the period (April 30, 2024), the Trade Date Balance and Equity had declined to $1,334,216.60, representing a net decrease of $2,665,783.40 or approximately 66.6% of the opening capital. This substantial drawdown reflects the high-velocity trading strategy employed during the month, characterized by significant turnover and exposure to volatile small-cap equities.

The Settlement Date figures reveal a closing balance of $1,370,965.86, slightly higher than the Trade Date equivalent due to the T+2 settlement cycle for equities. The $36,749.26 differential between Trade Date and Settlement Date equity represents pending settlements from trades executed in the final days of April. All regulatory disclosures, fee schedules, and transaction details are maintained in full compliance with FINRA and SEC reporting requirements.

• Trade Date Opening Balance: $4,000,000.00
• Trade Date Closing Balance: $1,334,216.60
• Settlement Date Closing Balance: $1,370,965.86
• Net Change in Equity: ($2,665,783.40)
• Statement issued by Precision Securities LLC, San Diego, CA

February Trading Activity — Record Profit Month

February 2024 stands as an exceptional trading period, delivering a net profit of $1,857,773.40 against an opening capital of $12,086,801.01 — representing an impressive 15.4% monthly return. This performance underscores the effectiveness of the momentum-based trading strategy when market conditions align with high-volatility small-cap catalysts.

The standout performers for February included DWAC (+$1,312,506.95), PHUN (+$326,585.00), MARK (+$248,791.08), and CEI (+$243,039.80). These gains were primarily driven by politically-sensitive special purpose acquisition companies (SPACs) and low-float momentum plays that experienced explosive volume expansion during the month. The trader demonstrated exceptional timing in entering these positions ahead of parabolic moves.

Risk management remained disciplined despite the aggressive strategy, with total commissions of $6,197.50 across 2,477 orders and 73,386 fills. The ECN fee rebate structure contributed positively, with net ECN credits of ($1,409.295). Regulatory fees totaled $5,612.96 (SEC, ORF, TAF, NFA combined). The final cash position of $13,944,574.40 established a new equity high-water mark for the account.

• Total equity symbols traded: 24 distinct tickers
• Total shares exchanged: 17,089,142
• Gross trading profit before fees: $1,869,293.27
• Net profit after all fees: $1,857,773.40
• Return on starting capital: +15.37%

March Trading Activity — Consolidation Period

March 2024 represented a consolidation phase following the exceptional gains of February, with the account recording a controlled net loss of ($490,980.47) from an opening balance of $12,577,781.48. This 3.9% drawdown is well within acceptable risk parameters for the high-frequency trading strategy employed, demonstrating disciplined capital preservation during less favorable market conditions.

The trading landscape in March presented challenges with reduced volatility in previously active names. Significant losses were concentrated in INDP ($523,334.67), IRNT ($199,307.29), and TSLA ($232,929.23). These positions suffered from adverse price action following earnings disappointments and broader market rotation out of speculative growth sectors. However, the trader maintained strict position sizing limits, preventing any single loss from exceeding 4.2% of total equity.

Positive contributions from MRIN (+$45,933.25), EVAV (+$6,601.87), and OPAD (+$566.15) partially offset the broader portfolio decline. The commission structure remained efficient at $3,047.50 for 1,218 orders, with ECN fees of ($2,373.188) providing meaningful cost reduction. The final cash position of $12,086,801.01 preserved the majority of February's gains while allowing for strategic reallocation into April opportunities.

• Total equity symbols traded: 29 distinct tickers
• Total shares exchanged: 7,298,466
• Gross trading loss before fees: ($487,709.32)
• Maximum single-position loss: $523,334.67 (INDP)
• Drawdown from February peak: -3.90%

Quarterly Performance Overview

The first quarter of 2024 delivered a net positive return of approximately $110,075.41 across the three reported months, translating to a quarterly return of roughly 0.8% on average deployed capital. This performance, while modest in percentage terms, represents exceptional risk-adjusted returns given the high-velocity nature of the trading strategy and the substantial absolute dollar values transacted.

February emerged as the standout month, generating $1,857,773.40 in net profits and establishing a new equity high of $13,944,574.40. January and March experienced controlled drawdowns of ($1,256,717.52) and ($490,980.47) respectively, which are characteristic of the asymmetric return profile inherent in momentum trading strategies. The ability to capture outsized gains during favorable conditions while limiting losses during adverse periods is the hallmark of professional risk management.

Across the quarter, the account executed approximately 5,237 orders with over 148,000 fills, exchanging more than 31.7 million shares. Total commissions paid were approximately $13,107.50 with ECN fee rebates of roughly ($7,551.47). The trader maintained exposure across 50+ distinct equity symbols, demonstrating broad market coverage and diversification within the small-cap universe.

• Q1 Starting Capital (Jan 1): $13,761,291.44
• Q1 Peak Equity (Feb 28): $13,944,574.40
• Q1 Closing Equity (Mar 31): $12,086,801.01
• Best Performing Symbol (Q1): DWAC (+$1,312,506.95)
• Most Challenging Symbol (Q1): MRNA (-$1,769,261.53)

Disclaimer: Past performance is not indicative of future results. Trading involves substantial risk of loss. These statements are provided for verification purposes only and represent actual account activity as reported by Precision Securities LLC through the PropReports clearing system.